These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22837101)

  • 1. In vivo infection by Trypanosoma cruzi: a morphometric study of tissue changes in mice.
    Esperandim VR; da Silva Ferreira D; Sousa Rezende KC; Cunha WR; Saraiva J; Bastos JK; Andrade E Silva ML; de Albuquerque S
    Parasitol Res; 2013 Jan; 112(1):431-6. PubMed ID: 22837101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi.
    Esperandim VR; da Silva Ferreira D; Rezende KC; Cunha WR; Saraiva J; Bastos JK; e Silva ML; de Albuquerque S
    Exp Parasitol; 2013 Apr; 133(4):442-6. PubMed ID: 23274812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.
    Esperandim VR; da Silva Ferreira D; Saraiva J; Silva ML; Costa ES; Pereira AC; Bastos JK; de Albuquerque S
    Parasitol Res; 2010 Aug; 107(3):525-30. PubMed ID: 20440625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.
    Saraiva J; Lira AA; Esperandim VR; da Silva Ferreira D; Ferraudo AS; Bastos JK; E Silva ML; de Gaitani CM; de Albuquerque S; Marchetti JM
    Parasitol Res; 2010 Feb; 106(3):703-8. PubMed ID: 20107838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
    de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML
    Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in silico anti-inflammatory mechanism of action of the semisynthetic (-)-cubebin derivatives (-)-hinokinin and (-)-O-benzylcubebin.
    Lima TC; Lucarini R; Volpe AC; de Andrade CQJ; Souza AMP; Pauletti PM; Januário AH; Símaro GV; Bastos JK; Cunha WR; Borges A; da Silva Laurentiz R; Conforti VA; Parreira RLT; Borges CHG; Caramori GF; Andriani KF; E Silva MLA
    Bioorg Med Chem Lett; 2017 Jan; 27(2):176-179. PubMed ID: 27955811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
    Cencig S; Coltel N; Truyens C; Carlier Y
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1216. PubMed ID: 21738811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo and in Silico Trypanocidal Activity Evaluation of (-)-Cubebin Encapsulated in PLGA Microspheres as Potential Treatment in Acute Phase.
    Neres NBR; Montagnini D; Ferreira DS; Parreira RLT; Orenha RP; Lima TC; Molina EF; Cunha WR; Silva MLA; Esperandim VR
    Chem Biodivers; 2021 Jun; 18(6):e2100052. PubMed ID: 33905595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin treatment provides protection against Trypanosoma cruzi infection.
    Nagajyothi F; Zhao D; Weiss LM; Tanowitz HB
    Parasitol Res; 2012 Jun; 110(6):2491-9. PubMed ID: 22215192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of (-)-cubebin by
    Arruda C; Eugênio DS; Moreira MR; Símaro GV; Bastos JK; Martins CHG; Silva MLA; Veneziani RCS; Vieira PB; Ambrósio SR
    Nat Prod Res; 2018 Dec; 32(23):2803-2816. PubMed ID: 28982254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi.
    Saraiva J; Vega C; Rolon M; da Silva R; E Silva ML; Donate PM; Bastos JK; Gomez-Barrio A; de Albuquerque S
    Parasitol Res; 2007 Mar; 100(4):791-5. PubMed ID: 17053932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Hinokinin causes antigenotoxicity but not genotoxicity in peripheral blood of Wistar rats.
    Medola JF; Cintra VP; Pesqueira E Silva EP; de Andrade Royo V; da Silva R; Saraiva J; Albuquerque S; Bastos JK; Andrade E Silva ML; Tavares DC
    Food Chem Toxicol; 2007 Apr; 45(4):638-42. PubMed ID: 17141387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro anthelmintic activity of the crude hydroalcoholic extract of Piper cubeba fruits and isolated natural products against gastrointestinal nematodes in sheep.
    de Paula Carlis MS; Féboli A; de Laurentiz AC; da Silva Filardi R; de Oliveira AHP; Andrade E Silva ML; Dos Anjos LA; Guidi Magalhães L; da Silva de Laurentiz R
    Vet Parasitol; 2019 Nov; 275():108932. PubMed ID: 31600614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity and antimutagenicity of (-)-hinokinin a trypanosomicidal compound measured by Salmonella microsome and comet assays.
    Resende FA; Barbosa LC; Tavares DC; de Camargo MS; de Souza Rezende KC; E Silva ML; Varanda EA
    BMC Complement Altern Med; 2012 Oct; 12():203. PubMed ID: 23114276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage and nitric oxide synthesis in experimentally infected Balb/c mice with Trypanosoma cruzi.
    Ribeiro DA; Calvi SA; Picka MM; Persi E; de Carvalho TB; Caetano PK; Nagoshi LR; Lima CR; Machado JM; Salvadori DM
    Exp Parasitol; 2007 Jul; 116(3):296-301. PubMed ID: 17286971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease.
    Sbaraglini ML; Bellera CL; Fraccaroli L; Larocca L; Carrillo C; Talevi A; Alba Soto CD
    Int J Antimicrob Agents; 2016 Jul; 48(1):91-95. PubMed ID: 27216381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: evaluation of (-)-cubebin derivatives activity in the messenger RNAs processing.
    Andrade e Silva ML; Cicarelli RM; Pauletti PM; Luz PP; Rezende KC; Januário AH; da Silva R; Pereira AC; Bastos JK; de Albuquerque S; Magalhães LG; Cunha WR
    Parasitol Res; 2011 Aug; 109(2):445-51. PubMed ID: 21327990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.